Skip to main content
Canna~Fangled Abstracts

Effects of cannabidiol in post-stroke mood disorders in neonatal rats

By February 15, 2024February 20th, 2024No Comments

. 2024 Feb 15.

doi: 10.1038/s41390-024-03077-8.

Online ahead of print.
María Villa 1, María Martínez-Vega 1, Laura Silva 1, Itziar Muneta-Arrate 2 3, Ana Gómez-Soria 4, Carolina Muguruza 2 3, Aarón Del Pozo 1, María de Hoz-Rivera 1, Angela Romero 1, Luis F Callado 2 3 5, Maria José Casarejos 4, José Martínez-Orgado 6 7
Affiliations 

Abstract

Background: Neonatal rats can manifest post-stroke mood disorders (PSMD) following middle cerebral artery occlusion (MCAO). We investigated whether cannabidiol (CBD) neuroprotection, previously demonstrated in neonatal rats after MCAO, includes prevention of PSMD development.

Methods: Seven-day-old Wistar rats (P7) underwent MCAO and received either vehicle or 5 mg/kg CBD treatment. Brain damage was quantified by MRI, and neurobehavioral and histological (TUNEL) studies were performed at P14 and P37. PSMD were assessed using the tail suspension test, forced swimming test, and open field tests. The dopaminergic system was evaluated by quantifying dopaminergic neurons (TH+) in the Ventral Tegmental Area (VTA), measuring brain dopamine (DA) concentration and DA transporter expression, and assessing the expression and function D2 receptors (D2R) through [35S]GTPγS binding. Animals without MCAO served as controls.

Results: CBD reduced MCAO-induced brain damage and improved motor performance. At P14, MCAO induced depressive-like behavior, characterized by reduced TH+ cell population and DA levels, which CBD did not prevent. However, CBD ameliorated hyperactivity observed at P37, preventing increased DA concentration by restoring D2R function.

Conclusions: These findings confirm the development of PSMD following MCAO in neonatal rats and highlight CBD as a neuroprotective agent capable of long-term functional normalization of the dopaminergic system post-MCAO.

Impact: MCAO in neonatal rats led to post-stroke mood disorders consisting in a depression-like picture in the medium term evolving towards long-term hyperactivity, associated with an alteration of the dopaminergic system. The administration of CBD after MCAO did not prevent the development of depressive-like behavior, but reduced long-term hyperactivity, normalizing dopamine receptor function. These data point to the importance of considering the development of depression-like symptoms after neonatal stroke, a well-known complication after stroke in adults. Our work confirms the interest of CBD as a possible treatment for neonatal stroke.

PubMed Disclaimer

References

    1. Wang, Z. et al. Diversiform etiologies for poststroke depression. Front. Psychiatry 10, 761 (2019). – DOI
    1. Villa, R. F., Ferrari, F. & Moretti, A. Post-stroke depression: Mechanisms and pharmacological treatment. Pharmacol. Ther. 184, 131–144 (2018). – DOI – PubMed
    1. Lehman, L. L. & Rivkin, M. J. Perinatal arterial ischemic stroke: Presentation, risk factors, evaluation, and outcome. Pediatr. Neurol. 51, 760–768 (2014). – DOI – PubMed
    1. Kirton, A. et al. Symptomatic neonatal arterial ischemic stroke: The International Pediatric Stroke Study. Pediatrics 128, e1402–e1410 (2011). – DOI – PubMed
    1. Álvarez-García, M., Cuellar-Flores, I., Sierra-García, P. & Martínez-Orgado, J. Mood disorders in children following neonatal hypoxic-ischemic encephalopathy. PLoS One 17, e0263055 (2022). – DOI – PubMed – PMC

LinkOut – more resources

Leave a Reply